(Q35030576)

5 August 2017

0 references

Long-term results of a randomized controlled trial in childhood IgA nephropathy (English)

1 reference

5 August 2017

Koichi Kamei

1

1 reference

5 August 2017

Koichi Nakanishi

2

1 reference

5 August 2017

Shuichi Ito

3

1 reference

5 August 2017

Mari Saito

4

1 reference

5 August 2017

Mayumi Sako

5

1 reference

5 August 2017

Kenji Ishikura

6

1 reference

5 August 2017

Hiroshi Hataya

7

1 reference

5 August 2017

Masataka Honda

8

1 reference

5 August 2017

Kazumoto Iijima

9

1 reference

5 August 2017

Norishige Yoshikawa

10

1 reference

5 August 2017

Japanese Pediatric IgA Nephropathy Treatment Study Group

11

1 reference

5 August 2017

publication date

14 April 2011

1 reference

Clinical Journal of the American Society of Nephrology

5 August 2017

published in

1 reference

5 August 2017

volume

6

1 reference

5 August 2017

issue

6

1 reference

5 August 2017

page(s)

1301-1307

1 reference

Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109925

Efficacy and safety of glucocorticoids therapy for IgA nephropathy: a meta-analysis of randomized controlled trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109925

Improved renal survival in Japanese children with IgA nephropathy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109925

The IgA nephropathy treatment dilemma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109925

Factors predicting progression of IgA nephropathies.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109925

Predicting progression in IgA nephropathy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109925

Pathophysiology and treatment of IgA nephropathy in children

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109925

Evidence-based assessment of treatment options for children with IgA nephropathies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109925

Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109925

Corticosteroids in IgA nephropathy: a randomised controlled trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109925

Prediction of creatinine clearance from serum creatinine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109925

A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109925

Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109925

Efficacy and safety of lisinopril for mild childhood IgA nephropathy: a pilot study

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109925

Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109925

Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109925

Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109925

Controlled, prospective trial of steroid treatment in IgA nephropathy: a limitation of low-dose prednisolone therapy

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109925

Factors associated with progression of IgA nephropathy are related to renal function--a model for estimating risk of progression in mild disease.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109925

Can immunosuppressive drugs slow the progression of IgA nephropathy?

25 October 2018

1 reference

12 December 2020

Alternate-day prednisone therapy in IgA nephropathy. Preliminary analysis of a prospective, randomized, controlled trial

1 reference

12 December 2020

Treatment of IgA nephropathy

1 reference

12 December 2020

IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria

1 reference

12 December 2020

Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial

1 reference

12 December 2020

Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy

1 reference

12 December 2020

Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy

1 reference

12 December 2020

Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial

1 reference

12 December 2020

Prognostic Indicators in Childhood IgA Nephropathy

1 reference

12 December 2020

A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group

1 reference

12 December 2020

Identifiers

DOI

10.2215/CJN.08630910

1 reference

5 August 2017

1 reference

5 August 2017

1 reference